The article discusses the impact of the Trump administration's chaos on the U.S. Food and Drug Administration (FDA) and its drug review and approval processes. It reports that the FDA has slowed down its drug reviews and approvals due to the ongoing government shutdown. The shutdown has also resulted in the agency not accepting any new drug submissions. This situation has raised concerns about the potential delay in the availability of new treatments for patients. The article suggests that the turmoil in the Trump administration has contributed to the disruption in the FDA's operations, which could have significant implications for the pharmaceutical industry and the healthcare system as a whole. The article emphasizes the need for a stable and functional FDA to ensure the timely approval of safe and effective drugs for the benefit of the public.
Oct 21, 2025 → Nov 6, 2025
The article discusses the impact of the Trump administration's cuts on food inspections in the United States. According to the report, American inspections of foreign food facilities have reached historic lows in 2019. This reduction in…
Read original at Ars Technica →2 updates from 1 source over 2 weeks.
The article discusses the impact of the Trump administration's cuts on food inspections in the United States. According to the report, American inspections of foreign food facilities have reached historic lows in 2019.…
Read original at Ars Technica →The article discusses the impact of the Trump administration's chaos on the U.S. Food and Drug Administration (FDA) and its drug review and approval processes. It reports that the FDA has slowed down its drug reviews…
Read original at Ars Technica →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
The article discusses the impact of the Trump administration's cuts on food inspections in the United States. According to the report, American inspections of foreign food facilities have reached historic lows in 2019. This reduction in…
View source →The article discusses the impact of the Trump administration's chaos on the U.S. Food and Drug Administration (FDA) and its drug review and approval processes. It reports that the FDA has slowed down its drug reviews and approvals due to…
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Long-running fight over Trump-backed maps takes another turn as absentee voting is already under way in Missouri. This blog is now closed. Sign up for US Breaking News emails Xi…
This new task force is Trump's latest response to the debate over AI safety.
The Trump administration’s decision to revoke the visa of a Peruvian judge who sided with a Chinese company in a port dispute puts a new spotlight on the growing US-China rivalry…
As Bosnians vote in an election this weekend, the country is embracing the US president’s family and friends.
On Equity, we discussed the Trump administration's attempts to rebrand AI.
Donald Trump and Xi Jinping discuss Taiwan arms sales every time they get together but the American stance on the self-ruled island remains unchanged following the Chinese…
